期刊文献+

多时段血糖控制对糖尿病心血管病变转归及与TNF-α和IGF-1关系的研究 被引量:2

Study on the relationship between multi-time blood glucose control and TNF-α,IGF-1 and disease turnover of diabetic cardiovascular disease
下载PDF
导出
摘要 目的探讨多时段血糖控制在糖尿病心血管病变治疗中的作用。方法对76例确诊为2型糖尿病的病人每月进行多时段血糖监测,并根据结果进行降糖药物调整使血糖稳定;而对照组的35例患者则根据空腹及早餐后血糖监测调整降糖药物。所有病人定期检查血糖、血压及HbA1c、心电图、心脏B超、动态心电图等;所有观察对象进行受试前后TNF-α和IGF-1的检测。结果多时段血糖控制组其心血管病变改善及稳定的阳性率高于对照组,而发生心血管病变加重的阳性率低于对照组;多时段血糖监测与控制的糖尿病病人2年后TNF-α和IGF-1水平低于对照组(P<0.05)。结论多时段血糖控制可延缓2型糖尿病心血管病变的发生和发展,并对心血管病变有改善作用,能降低TNF-α和IGF-1的表达。 Objective To explore the effect of multi-time blood glucose monitoring on diabetic cardiovascular disease. Method 76 diagnosed type 2 diabetic patients of the multi-time control group were underwent multi-time glucose monitoring every month and adjusted hypoglycemic drug to stable blod glucose, while 35 patients of the control group were adjusted their hypoglycemic drug according only to fasting and postprandial blood glucose. All patients were regularily measured with blood glucose, blood pressure, HbAll, ECG, cardiac B ultrasound, and DCG. TNF-α and IGF-1 of the two groups before and after study were measured as well. Result The rates of improvement and stability of diabetic cardiovascular disease in multi-time group were higher than those in control group, and their level of TNF-α and IGF-1 were lower than those in control group. Conclusion Multi-time blood glucose control can defer the onset of and development of complication of diabetic cardiovascular disease in type 2 diabetes, improve cardiovascular disease, and decrease the expression of TNF-α and IGF-1.
出处 《微创医学》 2012年第5期462-465,共4页 Journal of Minimally Invasive Medicine
基金 广西自然科学基金(合同号:2002019)
关键词 糖尿病 心血管病变 多时段血糖监测与控制 TNF-Α IGF-1 Diabetes Cardiovascular disease Multi-time blood glucose test and control Tumor necrosis factor-α Insulin-like growth factor-1
  • 相关文献

参考文献7

  • 1贾伟平.血糖控制达标是预防糖尿病并发症的关键[J].上海医学,2005,28(1):1-3. 被引量:46
  • 2Fernandez-Real JM, Ricart W. Insulin resistance and cardiovascular inflammatory syndrome[ J]. Endocrine Reviews,2003,24(3 ) :278 - 301.
  • 3Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progrvssion of long term complications in insulin-dependent diabetes mellitus [ J]. N Engl J Med, 1993,329 (14) :977 - 986.
  • 4UK Prospective Diabetes Study Group. Intensive blood glucose con- trol with sulphonylureas or insulin compared with conventional treat- ment and risk of complications in patient with type 2 diabetes( UKP- DS33) [J]. Lancet, 1998,352(9 131 ) :837 -853.
  • 5Strtton IM, Adler AI, Neil HA, et al. Association of glycaemia macro- vascular and microvascular complications of type 2 diabetes ( UKPDS35 ) : prospective observational study [ J ]. BMJ, 2000, 321 (7258) :405 -412.
  • 6American Diabetes Association. Implications of the diabetes control and complications trial [ J ]. Diabetes Care, 2003,26 ( Suppl 1 ) : 525 - 527.
  • 7Hanssen KF. Blood glucose control and microvascular and macrivas- cular complications in diabetes [ J ]. Diabetes, 1997,46 (Suppl 2 ) : s101 - 103.

二级参考文献12

  • 1贾伟平,于浩泳,项坤三.胰岛素脉冲样分泌的意义及临床应用[J].中华内分泌代谢杂志,2004,20(4). 被引量:6
  • 2潘长玉,田慧,刘国良,李秀钧,傅祖植,陈家伟,暨亚洲糖尿病管理中国协作组.中国城市中心医院糖尿病健康管理调查[J].中华内分泌代谢杂志,2004,20(5):420-424. 被引量:193
  • 3姜素英,左玉华,张和平,徐文,刘芳,贾伟平.社区糖尿病治疗达标现状分析[J].上海医学,2005,28(1):30-32. 被引量:31
  • 4卫生部疾病控制司 中华医学会糖尿病学分会.中国糖尿病防治指南[Z].,2003.4-6.
  • 5DCCT Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in IDDM. N Engl J Med, 1993, 329: 977-987.
  • 6The diabetes control and complications trial/epidemiology of diabetes interventions and complications research group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med, 2000,342:381- 389.
  • 7Nathan DM, l.achin J,Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med, 2003,348: 2294-2303.
  • 8UKPAD Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventiional treatment and risk of complications in patients with type 2 diabetes(UKPDS33). Lancet, 1998, 352:837-853.
  • 9Stevens RJ, Coleman RI., Adler AI, et al. Risk factors for myocardial infarction case falality and stroke case fatality in type 2 diabetes. Diabetes Care, 2004, 27: 201-207.
  • 10Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care, 1999, 22: 920-924.

共引文献45

同被引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部